Actinium Pharmaceuticals, Inc. (ATNM)
NYSEAMERICAN: ATNM · Real-Time Price · USD
1.220
+0.030 (2.52%)
At close: Sep 18, 2026, 4:00 PM EDT
1.250
+0.030 (2.46%)
After-hours: Sep 18, 2026, 8:00 PM EDT
Actinium Pharmaceuticals Market Cap
Actinium Pharmaceuticals has a market cap or net worth of $38.36 million as of September 18, 2026. Its market cap has decreased by -23.59% in one year.
Market Cap
38.36M
Enterprise Value
3.23M
1-Year Change
-23.59%
Ranking
Category
Stock Price
$1.22
ChartMarket Cap Chart
Since December 27, 2012, Actinium Pharmaceuticals's market cap has increased from $16.70M to $38.36M, an increase of 129.69%. That is a compound annual growth rate of 6.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 38.40M | -9.43% |
| Dec 31, 2025 | 42.40M | 7.89% |
| Dec 31, 2024 | 39.30M | -71.79% |
| Dec 29, 2023 | 139.30M | -48.67% |
| Dec 30, 2022 | 271.40M | 104.98% |
| Dec 31, 2021 | 132.40M | 24.91% |
| Dec 31, 2020 | 106.00M | 195.26% |
| Dec 31, 2019 | 35.90M | -19.87% |
| Dec 31, 2018 | 44.80M | -15.63% |
| Dec 29, 2017 | 53.10M | 8.81% |
| Dec 30, 2016 | 48.80M | -64.04% |
| Dec 31, 2015 | 135.70M | -23.20% |
| Dec 31, 2014 | 176.70M | 26.85% |
| Dec 31, 2013 | 139.30M | 734.13% |
| Dec 31, 2012 | 16.70M | - |
| Dec 27, 2012 | 16.70M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Annovis Bio | 44.31M |
| Metagenomi Therapeutics | 43.44M |
| Mereo BioPharma Group | 42.48M |
| Seres Therapeutics | 41.85M |
| Veru Inc. | 39.56M |
| Karyopharm Therapeutics | 38.56M |
| aTyr Pharma | 37.68M |
| Celularity | 37.34M |